RA CAPITAL MANAGEMENT, L.P. - 02 Apr 2024 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)

Reporting relationship: 10%+ Owner
Issuer ticker: BOLD
Reported as of: 02 Apr 2024
Net transaction value: +$5,000,000
SEC form: 4
Accepted by SEC: 04 Apr 2024, 16:15:15 UTC
Prior SEC filing: 29 Mar 2024
Next SEC filing: 15 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.

Key filing fact

RA CAPITAL MANAGEMENT, L.P. filed Form 4 for Boundless Bio, Inc. (BOLD) on 04 Apr 2024.

Key facts

This page summarizes RA CAPITAL MANAGEMENT, L.P.'s Form 4 filing for Boundless Bio, Inc. (BOLD).
8 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 04 Apr 2024, 16:15.

Change

Previous filing in this sequence was filed on 29 Mar 2024.
Current net transaction value: +$5,000,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BOLD transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,587,912
Change %
Price
Shares after: 1,587,912
Date: 02 Apr 2024
Ownership: See footnotes
Footnotes: F1, F2, F3

BOLD transaction

Common Stock

Purchase

Transaction value: $4,750,000
Shares: +296,875
Change %: +19%
Price: $16.00^*
Shares after: 1,884,787
Date: 02 Apr 2024
Ownership: See footnotes
Footnotes: F2, F3

BOLD transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +280,219
Change %
Price
Shares after: 280,219
Date: 02 Apr 2024
Ownership: See footnotes
Footnotes: F1, F3, F4

BOLD transaction

Common Stock

Purchase

Transaction value: $250,000
Shares: +15,625
Change %: +5.6%
Price: $16.00^*
Shares after: 295,844
Date: 02 Apr 2024
Ownership: See footnotes
Footnotes: F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BOLD transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -17,000,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Apr 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 871,794
Exercise price
Footnotes: F1, F2, F3

BOLD transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -3,000,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Apr 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 153,846
Exercise price
Footnotes: F1, F3, F4

BOLD transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -13,964,285
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Apr 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 716,118
Exercise price
Footnotes: F1, F2, F3

BOLD transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -2,464,286
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Apr 2024
Ownership: See footnotes
Underlying class: Common Stock
Underlying amount: 126,373
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

RA CAPITAL MANAGEMENT, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

On April 2, 2024, each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a 19.5-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The shares of Series B Preferred Stock and Series C Preferred Stock had no expiration date.

Footnote F2

Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

Footnote F3

RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Footnote F4

Held directly by the Nexus Fund II.